In the last trading session, 1.21 million shares of the Helius Medical Technologies Inc (NASDAQ:HSDT) were traded, and its beta was 1.28. Most recently the company’s share price was $0.51, and it changed around $0.07 or 14.55% from the last close, which brings the market valuation of the company to $2.89M. HSDT currently trades at a discount to its 52-week high of $7.19, offering almost -1309.8% off that amount. The share price’s 52-week low was $0.37, which indicates that the current value has risen by an impressive 27.45% since then.
Helius Medical Technologies Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended HSDT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Helius Medical Technologies Inc is expected to report earnings per share of -0.94 for the current quarter.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Instantly HSDT has showed a green trend with a performance of 14.55% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.5304 on recent trading dayincreased the stock’s daily price by 3.85%. The company’s shares are currently down -24.12% year-to-date, but still up 0.69% over the last five days. On the other hand, Helius Medical Technologies Inc (NASDAQ:HSDT) is -32.19% down in the 30-day period.
Helius Medical Technologies Inc (HSDT) estimates and forecasts
The year-over-year growth rate is expected to be -27.33%, down from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 100k in revenue for the current quarter. 1 analysts expect Helius Medical Technologies Inc to make 100k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 134k and 135k respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -25.37%. Forecasts for the next quarter put sales growth at -25.93%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 63.34%.
HSDT Dividends
Helius Medical Technologies Inc’s next quarterly earnings report is expected to be released in April.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 16.64 shares worth $8462.0, making up 0.29% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 12.6 shares worth around $6407.0, which represents about 0.22% of the total shares outstanding.
